Table 2 ART, immunological and virological statuses and healthcare coverage of adolescents living with HIV from 11 ART clinics in Cambodia
|  | Total (n = 328) | Males (n = 169) | Females (n = 159) |  |
|---|---|---|---|---|
n (%) | n (%) | n (%) | P-value* | |
Antiretroviral therapy (ART) | ||||
Mean travel time to ART clinic (min) | 48.2 ± 43.4 | 46.1 ± 41.2 | 55.5 ± 45.5 | 0.36 |
Type of ART regimen | Â | Â | Â | 0.91 |
 First line | 183 (82.4) | 140 (82.8) | 131 (82.4) |  |
 Second line | 36 (16.2) | 29 (17.2) | 27 (17.6) |  |
Time since ART started (in years) | 8.2 ± 3.3 | 8.3 ± 3.4 | 7.8 ± 3.3 | 0.20 |
Mean cost to travel to ART clinic (USD) | 3.4 ± 3.9 | 3.5 ± 3.9 | 3.3 ± 4.0 | 0.61 |
Visual Adherence Scale (%) | 95.4 ± 9.6 | 95.3 ± 9.6 | 95.4 ± 9.7 | 0.91 |
Immunological and virological status | ||||
Initial CD4 count (mean cells/mm3) | 632 ± 1101 | 777 ± 1460 | 632 ± 460 | 0.35 |
Latest CD4 count (mean cells/mm3) | 672 ± 284 | 683 ± 314 | 660 ± 250 | 0.44 |
First viral load count (copies) | 34,375 ± 13,958 | 37,868 ± 13,205 | 30,662 ± 14,748 | 0.64 |
Latest viral load count (copies) | 9268 ± 6407 | 4103 ± 1573 | 14,759 ± 9041 | 0.13 |
Viral suppression | 252 (76.8) | 131 (77.5) | 121 (76.1) | 0.76 |
Healthcare access and coverage | ||||
Ability to cover health expenses | Â | Â | Â | 0.11 |
 No | 181 (55.2) | 86 (50.9) | 95 (59.7) |  |
 Yes | 147 (44.8) | 83 (49.3) | 64 (40.3) |  |
Family has an ID poor card | Â | Â | Â | 0.04 |
 No | 190 (57.9) | 88 (52.1) | 102 (64.2) |  |
 Yes | 112 (34.2) | 63 (37.3) | 49 (30.8) |  |
 Don’t know | 26 (7.9) | 18 (10.7) | 8 (5.0) |  |
Access to the health equity fund |  |  |  | < 0.001 |
 No | 185 (56.4) | 109 (64.5) | 76 (47.8) |  |
 Yes | 126 (38.4) | 45 (35.7) | 81 (50.9) |  |
 Don’t know | 17 (5.2) | 15 (8.9) | 2 (1.3) |  |
Covered by a health insurance scheme | Â | Â | Â | 0.02 |
 No | 289 (88.1) | 148 (87.6) | 141 (88.7) |  |
 Yes | 6 (1.8) | 0 (0.0) | 6 (3.8) |  |
 Don’t know | 33 (10.1) | 21 (12.4) | 12 (7.5) |  |